3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

News:

Welcome to 3StocksOnFire! US stock trading community (2005-2010) with 451+ documented trades and 15,000+ members. View Portfolios | Stock Articles | Quotes

Main Menu

VPHM - Sector: Healthcare---Industry: Biotechnology & Drugs

Started by eliteG, June 02, 2005, 08:52:03 PM

Previous topic - Next topic

calven

StockGravity.com - The Forces that Move Stocks!
http://www.stockgravity.com

KCScott

In at 16.80

Move is starting ahead of Monday's add to the Bio index and today's option expiration.

Nice to have saved $2.00 per share vs. my previous sell price.


Those that think money can't buy happiness, don't know where to shop

brandyjoco

It looks like VPHM will close at almost HOD.  Do you think it is okay to buy now?  Ahhhh.... I bought 3000 shares in the 17.20's...  I hope this works out - it is so undervalued!
Brandyjoco

brandyjoco

Looks like VPHM is starting to move up....
Brandyjoco

KCScott

Brandy,

IMO, Barring any unforeseen "bad news" - you can sleep on this one through the end of the year.

It won't be a huge Parabolic rise, just a gradual ascent back towards 22-24

Of all my current holdings, I'd rank this one as best to reach the target by EOY.

Good Luck
Those that think money can't buy happiness, don't know where to shop

SmartWrasse

I'm back in the mix 

Now we need some panick buying.

brandyjoco

Wow, this is moving pretty steady and fast. I will feel better when we cross the 50 MA. That is at $19.08?
Brandyjoco

brandyjoco

I got out at 18.15..... Anyone else left here?
Brandyjoco

SmartWrasse

How did you know to get out before the 100,000 dump at 1 pm?

SmartWrasse

You must have got out with a stop I guess.  Looks like it has become just another crappy trading stock 

brandyjoco

I have ameritrade. They have 3D level II where you can see the sells stacking up as large mountains against the small hills that are the buys. That told me it was going to drop because of too much resistance.

When will be a good point to buy back?
Brandyjoco

SmartWrasse

I am no TA expert, but it looks like it is right around a support /resistance line now.  What I would like to see now that I am out is go a bit more than a $ lower for a buy then sell as soon as it turns weak again.  Anyone out there with a solid plan?

la-onda

fyi:
VPHM: Short Interest UP 24.2% to 4.5M in Nov 2005
Friday , November 25, 2005 13:22 ET

According to new short interest data from NASDAQ, short interest for Viropharma, Incorporated (NasdaqNM: VPHM) INCREASED 24.2% to 4,482,392 shares for the month ended mid-November, 2005.

SYMBOL     OCTOBER        NOVEMBER          CHANGE       %CHANGE  DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
VPHM           3,607,594       4,482,392        +874,798       +24.25%           2

Based on VPHM's 20-day average daily share volume of 3,789,530, it would require approximately 2 day(s) of buying to cover this short interest.

TA Link:
Bulish Harami on the 25th of Nov
strong resistance @ 17.75$
http://www.stockta.com/cgi-bin/analysis.pl?symb=VPHM&num1=7&cobrand=&mode=stock

usedcasting

Hummm! What is the issue price going to be?
Good Luck All!

ViroPharma Incorporated Announces Public Offering of Common Stock
Monday November 28, 4:01 pm ET

EXTON, Pa., Nov. 28, 2005 (PRIMEZONE) -- ViroPharma Incorporated (NasdaqNM:VPHM - News) today announced that it plans to offer 7,000,000 shares of its common stock in a public offering. ViroPharma also intends to grant the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock. A preliminary prospectus supplement relating to the offering will be filed with the Securities and Exchange Commission but remains subject to completion.

ADVERTISEMENT
ViroPharma intends to use net proceeds from the offering for working capital and general corporate purposes. The Company may also use a portion of the net proceeds to repay or prepay all or a portion of its 6% subordinated convertible notes due March 2007 and for business development purposes.

Goldman, Sachs & Co. will act as the sole book-running manager for the offering. Piper Jaffray & Co. will act as the joint lead manager and SG Cowen & Co. LLC and Lazard Capital Markets LLC will be co-managers of the offering.

These shares will be issued pursuant to an effective shelf registration statement. This press release does not constitute an offer to sell or a solicitation of an offer to buy nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer, if at all, will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Printed copies of the preliminary and final prospectus supplement and base prospectus relating to the offering may be obtained, when available, from Goldman, Sachs & Co. (Attn: Prospectus Department, 85 Broad Street, New York, New York 10004, Phone: 212-902-1000). A preliminary prospectus supplement relating to the offering will be filed with the SEC, and will be available along with the base prospectus filed with the SEC in connection with the shelf registration, on the SEC's website at http://www.sec.gov/.
Know when to hold'em, know when to fold'em

la-onda

afterhours down  ??? :-\
ViroPharma to Offer 7M Shares of Stock
Monday November 28, 5:07 pm ET 
ViroPharma Plans to Offer 7 Million Shares of Its Common Stock in Public Offering


EXTON, Pa. (AP) -- Drug developer ViroPharma Inc. said Monday it plans to offer 7 million shares of its common stock in a public offering.
The company also said it intends to grant the underwriters a 30-day option to purchase up to an additional 1 million shares, and will use proceeds from the offering for working capital and general corporate purposes. The company may also use a portion of the proceeds to repay its debt and for business development purposes.

Shares of ViroPharma fell 89 cents, or 5.2 percent, to $16.11 in aftermarket activity, after closing down 73 cents, or 4 percent at $17 on the Nasdaq.


Real-Time ECN Get Real-Time ECN for: 




VIROPHARMA INC (RT-ECN)   
Symbol: VPHM
Last Trade: 15.64 Nov 28
After Hours Change:  1.36 (8.00%)
Today's Change:  2.09 (11.79%)
Bid: 15.52
Ask: 15.63